Naringin Ameliorates HIV-1 Nucleoside Reverse Transcriptase Inhibitors- Induced Mitochondrial Toxicity

By  

Current HIV Research, Vol. 14, Iss. 6, 2016-12 ,pp. : 506-516

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally- exposed to nucleoside reverse transcriptase inhibitors

By Divi Rao   Leonard Sarah   Kuo Maryanne   Walker Brettania   Orozco Christine   St. Claire Marisa   Nagashima Kunio   Harbaugh Steven   Harbaugh Jeffrey   Thamire Chandrasekhar   Sable Craig   Poirier Miriam  

Cardiovascular Toxicology, Vol. 5, Iss. 3, 2005-09 ,pp. : 333-346

Humana Press, Inc

Access to resources Recommend Favorite

Reverse Transcriptase Inhibitors as Microbicides

By  

Current HIV Research, Vol. 10, Iss. 1, 2012-01 ,pp. : 27-35

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors

By Calcagno A.   Tettoni M. C.   Simiele M.   Trentini L.   Montrucchio C.   D'Avolio A.   Di Perri G.   Bonora S.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 482-484

Oxford University Press

Access to resources Recommend Favorite

The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients

By  

Current HIV Research, Vol. 11, Iss. 3, 2013-04 ,pp. : 179-186

Bentham Science Publishers

Access to resources Recommend Favorite